Exchange operator Cboe quarterly profit tops Street expectations

3 February 2023 12:02 p.m. All figures in US dollars. Incyte Corp is expected to show an increase in its fourth quarter earnings to 58 cents​ per share according to the mean Refinitiv estimate from

* Xylem Inc is expected to show a rise in quarterly revenue when it reports results on February 7. * The Washington Washington Dc-based company is expected to report a 6.8% increase in revenue to

* Gorman-Rupp Co reported quarterly adjusted earnings of 11 cents​​ per share for the quarter ended in December. The lone analyst forecast for the quarter was for earnings of 18 cents per share. *

3 February 2023 11:57 a.m. ​All figures in US dollars. The profits announced by Gorman-Rupp Co in the fourth quarter were lower than the Refinitiv mean estimate of profits. The company reported

3 February 2023 11:57 a.m. All figures in US dollars. Xylem Inc is expected to show an increase in its fourth quarter earnings to 79 cents​ per share according to the mean Refinitiv estimate from

* Sonnet Biotherapeutics Holdings Inc is expected to report results on February 6 (estimated). * * ​Refinitiv's mean analyst estimate for Sonnet Biotherapeutics Holdings Inc is for a loss of $1.10 per

(Reuters) - Regeneron Pharmaceuticals Inc reported an about 46% plunge in its fourth-quarter profit on Friday, hurt by a drop in U.S. sales of its blockbuster eye drug, Eylea, and drying up of its

(Adds quarter details, background) Feb 3 (Reuters) - Regeneron Pharmaceuticals Inc reported an about 46% plunge in its fourth-quarter profit on Friday, hurt by a drop in U.S. sales of its blockbuster

(Adds analyst comment, updates share movement) By Sheila Dang Feb 3 (Reuters) - After a challenging 2022 in which advertising-dependent companies faced shrinking budgets and cratering stock prices,

* Premier Inc is expected to show a fall in quarterly revenue when it reports results on February 7. * The Charlotte North Carolina-based company is expected to report a 7.3% decrease in revenue to